Global trials are critical for developing orphan drugs because they provide the necessary platform to evaluate the safety, efficacy, and overall impact of these therapies on rare disease populations worldwide. Orphan drugs are specifically designed to treat rare diseases and face unique challenges during development, particularly due to the limited number of patients available for […]

Read More →

The nutraceutical industry has experienced significant growth in recent years, fueled by rising consumer demand for dietary supplements, functional foods, and natural health products. However, with this expansion comes heightened scrutiny from regulatory bodies, highlighting the challenges in nutraceutical clinical trials as a crucial aspect of successfully bringing new products to market. Unlike pharmaceuticals, nutraceuticals […]

Read More →

Thailand is rapidly emerging as a key player in the global clinical trial landscape, with the market expected to reach USD 3.5 billion by 2027. The country’s strategic location in Southeast Asia provides access to a diverse patient population, essential for robust clinical research. Moreover, Thailand’s healthcare system is well-equipped with state-of-the-art facilities and skilled […]

Read More →

Clinical trial site identification and feasibility are critical components of the clinical trial process. Selecting the right sites and ensuring they are feasible for conducting trials can greatly impact the success and efficiency of clinical trials. The process begins with identifying potential sites that have the appropriate infrastructure, patient population, and experience. The right site […]

Read More →